Abstract: A new process for the preparation of bicyclic peptide compounds Formula (I) in high yields of high purity, useful as intermediates for preparing compounds with pharmacological activity, is described.
Type:
Grant
Filed:
December 4, 2003
Date of Patent:
August 16, 2011
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Aldo Salimbeni, Davide Poma, Damiano Turozzi, Stefano Manzini, Carlo Alberto Maggi
Abstract: There are disclosed pharmaceutical compositions for topical administration or for use in mesotherapy, containing a PDE3 inhibitor as active ingredient, and their use in the treatment of cellulite.
Abstract: Non-peptide compounds of formula (I) having activity as specific antagonists of bradykinin (BK) B2 receptor. The compounds are chemically characterized by the presence of an alpha, alpha-disubstituted amino acid at least one amino group, free or salified, or the corresponding ammonium quaternary salt. These BK receptor antagonists are a novel class of medicaments which can be used in all the disorders in which the receptors are involved.
Type:
Grant
Filed:
June 5, 2003
Date of Patent:
February 17, 2009
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Federico Calvani, Fernando Catrambone, Patrizia Felicetti, Christopher Ingo Fincham, Alessandro Giolitti, Carlo Alberto Maggi, Laura Quartara, Cristina Rossi, Rosa Terracciano
Abstract: There are disclosed pharmaceutical compositions for topical administration or for use in mesotherapy, containing a PDE3 inhibitor as active ingredient, and their use in the treatment of cellulite.
Abstract: Described herein are compounds of formula (I) useful as antagonists of tachykinins in general, and in particular of neurokinin A; and the pharmaceutical formulations comprising the compounds of formula (I)
Type:
Grant
Filed:
October 28, 2002
Date of Patent:
September 25, 2007
Assignee:
Menarini Ricerche S.P.A.
Inventors:
Alessandro Sisto, Valerio Caciagli, Maria Altamura, Alessandro Giolitti, Valentina Fedi, Antonio Guidi, Danilo Giannotti, Nicholas Harmat, Rossano Nannicini, Franco Pasqui, Carlo Alberto Maggi
Abstract: Basic monocyclic compounds having general formula (I) useful as NK-2 antagonists are described, processes for their preparation and pharmaceutical compositions containing them are also described.
Type:
Grant
Filed:
October 17, 2000
Date of Patent:
March 21, 2006
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Enzo Perrotta, Danilo Giannotti, Maria Altamura, Sandro Giuliani, Carlo Alberto Maggi
Abstract: Disclosed are monocyclic compounds containing four bifunctional residues linked together via peptide or pseudopeptide bonds of the general formula (I):
having tachykinin receptor antagonist activity. In particular, compounds of formula I are shown to be neurokinin-2 (NK-2) antagonists useful in the treatment or prevention of disorders of the central nervous system, inflammatory diseases, asthma, or pain.
Type:
Grant
Filed:
July 12, 2000
Date of Patent:
August 24, 2004
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Raffaello Giorgi, Cristina Di Bugno, Danilo Giannotti, Carlo Alberto Maggi
Abstract: The present invention refers to compounds of general formula (I), the pharmaceutically acceptable salts thereof, the processes for their preparation, and the pharmaceutical compositions containing them.
Type:
Grant
Filed:
December 18, 2001
Date of Patent:
November 25, 2003
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Fabio Animati, Marco Berettoni, Mario Bigioni, Amalia Cipollone, Carlo Alberto Maggi
Abstract: A process for the preparation of polymorph A of zofenopril calcium salt in substantially pure form, which comprises: 1) reaction of S(−)-3-benzoylthio-2-methylpropanoic acid chloride with cis-4-phenylthio-L-proline in water at pH ranging from 9.0 to 9.5 and recovery of zofenopril in the acidic form; b) salification of acid zofenopril with a poyassium salt in alcoholic solution, and recovery of the resulting potassium salt; c) conversion of the potassium salt to the calcium salt by addition of zofenopril potassium salt aqueous solution to a CaCl2 aqueous solution at a temperature of 70-90° C. with simultaneous seeding to promote the precipitation of polymorph A.
Type:
Grant
Filed:
May 28, 2002
Date of Patent:
February 4, 2003
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Raffaello Giorgi, Antonio Giachetti, Carlo Mannucci, Anita Falezza
Abstract: It is described a hybrid molecule of formula GM-CSF-L-EPO or EPO-L-GM-CSF useful for the stimulation of hematopoiesis, comprising GM-CSF and EPO molecules fused together by means of a linker L having a variable length of amino acids, GM-CSF and EPO molecules being either complete molecules or fragments thereof. Such hybrid molecules exhibit a higher specifity of action on erythroid differentiation if compared to that of an equimolar mixture of not-linked GM-CSF and EPO molecules. Further, the present invention describes: DNA sequences encoding such hybrid molecules, which stimolate the hematopoiesis; plasmid vectors containing the genes encoding hybrid molecules and directing their synthesis in host cells; the use of such hybrid molecules for the preparation of a pharmaceutical composition and such pharmaceutical composition useful for stimolation of hematopoiesis.
Type:
Grant
Filed:
November 27, 1996
Date of Patent:
June 29, 1999
Assignee:
Menarini Ricerche S.p.A.
Inventors:
Antonio Mele, Rita De Santis, Cristina Carloni, Annamaria Coscarella